A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in ...

Researchers from Queen Mary University of London's School of Biological and Behavioural Sciences, using the simple fission yeast as a model, have shown that new TOR inhibitor rapalink-1 prolongs ...